Diane Lara

Libourne, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Factors influencing front line treatment of chronic lymphocytic leukemia: A French real-world study.

Factors influencing front line treatment of chronic lymphocytic leukemia: A French real-world study.

Journal: Cancer

Published: November 15, 2025

BRAF inhibitor plus rituximab in classical hairy cell leukaemia: A retrospective multicentre real-life study.

BRAF inhibitor plus rituximab in classical hairy cell leukaemia: A retrospective multicentre real-life study.

Journal: British journal of haematology

Published: October 02, 2025

Outcome of patients with accelerated and blast-phase myeloproliferative neoplasms not eligible for intensive chemotherapy or allogeneic hematopoietic cell transplantation treated by azacitidine alone or in combination-A FIM study.

Outcome of patients with accelerated and blast-phase myeloproliferative neoplasms not eligible for intensive chemotherapy or allogeneic hematopoietic cell transplantation treated by azacitidine alone or in combination-A FIM study.

Journal: HemaSphere

Published: March 17, 2025

Levofloxacin to Prevent Bacterial Infection in Patients With Acute Myeloid Leukemia Treated by Venetoclax and Azacitidine: A Toulouse-Bordeaux DATAML Registry Study.

Levofloxacin to Prevent Bacterial Infection in Patients With Acute Myeloid Leukemia Treated by Venetoclax and Azacitidine: A Toulouse-Bordeaux DATAML Registry Study.

Journal: Open forum infectious diseases

Published: November 05, 2024

Nodal cytotoxic peripheral T-cell lymphoma occurs frequently in the clinical setting of immunodysregulation and is associated with recurrent epigenetic alterations.

Nodal cytotoxic peripheral T-cell lymphoma occurs frequently in the clinical setting of immunodysregulation and is associated with recurrent epigenetic alterations.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: October 04, 2021

Common clonal origin of an EBV-positive diffuse large B cell lymphoma and a chronic myelomonocytic leukemia.

Common clonal origin of an EBV-positive diffuse large B cell lymphoma and a chronic myelomonocytic leukemia.

Journal: Leukemia & lymphoma

Published: June 12, 2019

A Recurrent Activating Missense Mutation in Waldenström Macroglobulinemia Affects the DNA Binding of the ETS Transcription Factor SPI1 and Enhances Proliferation.

A Recurrent Activating Missense Mutation in Waldenström Macroglobulinemia Affects the DNA Binding of the ETS Transcription Factor SPI1 and Enhances Proliferation.

Journal: Cancer discovery

Published: August 01, 2018

Azacytidine in combination with tyrosine kinase inhibitors induced durable responses in patients with advanced phase chronic myelogenous leukemia.

Azacytidine in combination with tyrosine kinase inhibitors induced durable responses in patients with advanced phase chronic myelogenous leukemia.

Journal: Leukemia & lymphoma

Published: November 29, 2017

Central nervous system relapse in patients over 80 years with diffuse large B-cell lymphoma: an analysis of two LYSA studies.

Central nervous system relapse in patients over 80 years with diffuse large B-cell lymphoma: an analysis of two LYSA studies.

Journal: Cancer medicine

Published: March 27, 2017

Showing 1-9 of 9

Last Updated: 09/26/2026